 |
|
Recent Developments in the Diagnosis, Treatment, and Prevention of Pulmonary Embolism
Glen E. Hastings, MD;
Donald S. Seery, MD;
Donald L. Vine, MD
Arch Fam Med. 1993;2(6):655-669.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Virchow R. Phlogose und Thrombose im Gefäbssstim. In: Virchow R, ed. Gesammelte Abhandlungen zur wissenschaftlichen Medicin. Frankfurt, Germany: Von Meidinger Sohn; 1856: 458-636.
2. Bell WR, Simon TL, DeMets DL. The clinical features of submassive and massive pulmonary emboli. Am J Med. 1977;62:355-360.
PUBMED
3. Leeper KV, Popovich H Jr, Adams D, Stein PD. Clinical manifestations of acute pulmonary embolism: Henry Ford Hospital experience: a five year review. Henry Ford Hosp Med J. 1988;36:29-34.
PUBMED
4. Stein PD, Willis PW, DeMets DL. History and physical examination in acute pulmonary embolism in patients without preexisting cardiac or pulmonary disease. Am J Cardiol. 1981;47:218-223.
PUBMED
5. Hull RD, Raskob GE, Carter CJ, et al. Pulmonary embolism in outpatients with pleuritic chest pain. Arch Intern Med. 1988;148:838-844.
FREE FULL TEXT
6. Stein PD, Terrin ML, Hales CA, et al. Clinical, laboratory, roentgenographic, and electrocar-diographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease. Chest. 1991;100:598-603.
PUBMED
7. Overton DT, Bocka JJ. The alveolar-arterial oxygen gradient in patients with documented pulmonary embolism. Arch Intern Med. 1988;148:1617-1619.
FREE FULL TEXT
8. Cvitanic O, Marino PL. Improved use of arterial blood gas analysis in suspected pulmonary embolism. Chest. 1989;95:48-51.
PUBMED
9. The PIOPED Investigators. Value of the ventilation/ perfusion scan in acute pulmonary embolism: results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). JAMA. 1990;263:2753-2759.
FREE FULL TEXT
10. Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis. 1975;17:259-270.
PUBMED
11. Novelline RA, Baltarowich OH, Athanasoulis CA. The clinical course of patients with suspected pulmonary embolism and negative pulmonary arteriogram. Radiology. 1978;126:561-567.
ABSTRACT
12. Cheely R, McCartney WH, Perry JR, et al. The role of noninvasive tests versus pulmonary arteriogram in the diagnosis of pulmonary embolism. Am J Med. 1981;70:17-22.
PUBMED
13. Mills SR, Jackson DC, Older RA, Heaston DK, Moore AV. The incidence etiologies and avoidance of complications of pulmonary angiography in a large series. Radiology. 1980;136:295-299.
FREE FULL TEXT
14. Dalen JE, Brooks HL, Johnson LW, Meister SG, Szucs MM, Dexter L. Pulmonary angiography in acute pulmonary embolism: indications techniques and results in 367 patients. Am Heart J. 1971;81:175-185.
PUBMED
15. Stein PD, Athanasoulis C, Alavi A, et al. Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation. 1992;85:462-468.
FREE FULL TEXT
16. Goldhaber SZ. Recent advances in the diagnosis and lytic therapy of pulmonary embolism. Chest. 1991;99(suppl):173S-179S.
PUBMED
17. Nicod P, Peterson K, Levine M, et al. Pulmonary angiography in severe chronic pulmonary hypertension. Ann Intern Med. 1987;107:565-568.
PUBMED
18. Hull RD, Raskob GE. Low probability lung scan findings: a need for change. Ann Intern Med. 1991;114:142-143.
FREE FULL TEXT
19. Biello DR, Maltar AG, McKnight RC, Siegel BA. Ventilation perfusion studies in suspected pulmonary embolism. Am J Radiol. 1979;133:1033-1037.
ABSTRACT
20. McNeil BJ. Ventilation perfusion studies and the diagnosis of pulmonary embolism. J Nucl Med. 1980;21:319-323.
FREE FULL TEXT
21. Hull RD, Hirsh J, Carter CJ, et al. Pulmonary angiography, ventilation scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med. 1983;98:891-899.
FREE FULL TEXT
22. Hull RD, Hirsh J, Carter CJ, et al. Diagnostic value of ventilation perfusion lung scanning in patient with suspected pulmonary embolism. Chest. 1985;88:819-828.
PUBMED
23. Hull RD, Raskob GE, Coates G, Panju AA. Clinical validity of a normal perfusion lung scan in patients with suspected pulmonary embolism. Chest. 1990;97:23-26.
PUBMED
24. The incidence of documented pulmonary embolism with "normal or near normal" scans in the PIOPED study was five of 131 patients. However, only 42% of those patients agreed to arteriography. In only 21 of the 131 patients did both radiologists interpret the scan as negative. In only three of these cases was arteriography obtained. Results were negative in all three. None of the remaining 18 patients had clinically apparent pulmonary embolism at the time of follow-up. Therefore, no patient whose V/Q scan was considered negative by two readers was subsequently proven to have pulmonary embolism. However, since arteriogaphy was not performed on 58% of the 131 patients with "normal or near normal" scans, the true incidence of false-negative "normal or near normal" V/Q scans cannot be determined. Since five of the 131 patients with "normal to near normal scans" had clinically documented pulmonary embolism, at least 4% of patients whose scans were read as normal by an experienced radiologist were subsequently shown to have had a pulmonary embolism. Thus, 4%, in our opinion, is the best estimate of the rate of error that the primary care physician might expect in community practice. 25. Kelley MA, Carson JL, Palevsky HI, Schwartz JS. Diagnosing pulmonary embolism: new facts and strategies. Ann Intern Med. 1991;114:300-306.
FREE FULL TEXT
26. Stein PD, Colemass RE, Gottschalk A, Saltzman HA, Terrin ML, Weg JG. Diagnostic utility of ventilation/perfusion lung scans in acute pulmonary embolism is not diminished by preexisting cardiac or pulmonary disease. Chest. 1991;100:604-606.
PUBMED
27. Bounameaux H, Cirafici P, de Moerloose P, et al. Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolism. Lancet. 1991;337:196-200.
PUBMED
28. Bounameaux H, Schneider PA, Slosman D, de Moerloose P, Reber G. Plasma D-dimer in suspected pulmonary embolism: a comparison with pulmonary angiography and ventilation/ perfusion scintography. Blood Coagul Fibrinolysis. 1990;1:577-579.
PUBMED
29. Hull RD, Raskob GE, Coates G, Panju AA, Gill GJ. A new noninvasive management strategy for patients with suspected pulmonary embolism. Arch Intern Med. 1989;149:2549-2555.
FREE FULL TEXT
30. Bone RC. Ventilation/perfusion scan in pulmonary embolism: 'the emperor is incompletely attired.' JAMA. 1990;263:2794-2795.
FREE FULL TEXT
31. Farfel Z, Shechter M, Vered Z, Rath S, Goor D, Gafni J. Review of echocardiographically diagnosed right heart entrapment of pulmonary emboli-in-transit with emphasis on management. Am Heart J. 1987;113:171-178.
PUBMED
32. Johnson ME, Furlong R, Schrank K. Diagnostic use of emergency department echocardiogram in massive pulmonary emboli. Ann Emerg Med. 1992;21:760-763.
PUBMED
33. Come PC. Echocardiographic evaluation of pulmonary embolism and its response to therapeutic interventions. Chest. 1992;101(suppl):151S-162S.
PUBMED
34. Goldhaber SZ, Morpurgo M, for the WHO/ISFC Task Force on Pulmonary Embolism. Diagnosis, treatment, and prevention of pulmonary embolism: report of the WHO/International Society and Federation of Cardiology Task Force. JAMA. 1992;268:1727-1733.
FREE FULL TEXT
35. Kasper W, Meinertz T, Henkel B, et al. Echocar-diographic findings in patients with proved pulmonary embolism. Am Heart J. 1986;112:1284-1290.
PUBMED
36. Kronik G, the European Working Group on Echocardiography. The European Cooperative Study on the Clinical Significance of Right Heart Thrombi. Eur Heart J. 1989;10:1046-1059.
FREE FULL TEXT
37. Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med. 1992;326:1240-1245.
ABSTRACT
38. Levine MN, Raskob GE, Hirsh J. Hemorrhagic complications of long term anticoagulative therapy: from the ACCP-NHLBI National Conference on Antithrombotic Therapy. Chest. 1986;89(suppl_2):16S-25S.
PUBMED
39. Landefeld CS, Anderson PA. Guideline-based consultation to prevent anticoagulant-related bleeding: a randomized controlled trial in a teaching hospital. Ann Intern Med. 1992;116:829-837.
PUBMED
40. Landefeld CS, McGuire E III, Rosenblatt MW. A bleeding risk index for estimating the probability of major bleeding in hospitalized patients starting anticoagulant therapy. Am J Med. 1990;89:569-578.
PUBMED
41. Hull RD, Raskob GE, Rosenbloom D, et al. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med. 1990;322:1260-1264.
ABSTRACT
42. Hull RD, Raskob GE, Rosenbloom D, et al. Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med. 1992;152:1589-1595.
FREE FULL TEXT
43. Hull RD, Raskob GE, Hirsh J, et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal vein thrombosis. N Engl J Med. 1986;315:1109-1114.
ABSTRACT
44. Hirsh J. Heparin. N Engl J Med. 1991;324:1565-1574.
PUBMED
45. Cruickshank MK, Levine MN, Hirsh J, Roberts R, Siguenza M. A standard nomogram for the management of heparin therapy. Arch Intern Med. 1991;151:333-337.
FREE FULL TEXT
46. Hirsh J, Dalen JE, Deykin D, Poller L. Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest. 1992;102(suppl 4):337S-351S.
PUBMED
47. Shojania AM, Telreault J, Turnbull G. The variations between heparin sensitivity of different lots of activated partial thromboplastin time reagents produced by the same manufacturer. Am J Clin Pathol. 1988;89:19-23.
PUBMED
48. Levine MN, Hirsh J, Landefeld S, Raskob G. Hemorrhagic complications of anticoagulant treatment. Chest. 1992;102(suppl 4):353S-363S.
49. Majerus PW, Broze GJ Jr, Miletich JP, Tollefsen DM. Anticoagulant, thrombolytic, and antiplatelet drugs. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. Goodman and Gilman's 'The Pharmacological Basis of Therapeutics.'8th ed. Elmsford, NY: Pergamon Press Inc; 1990:1311-1331. 50. Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med. 1980;68:122-140.
PUBMED
51. Ginsberg JS, Hirsh J, Turner DC, et al. Risks to the fetus of anticoagulant therapy during pregnancy. Thromb Haemost. 1989;61:197-203.
PUBMED
52. Ginsberg JS, Kowalchuk G, Hirsh J, et al. Heparin therapy during pregnancy: risks to the fetus and mother. Arch Intern Med. 1989;149:2233-2236.
FREE FULL TEXT
53. Ginsberg JS, Hirsh J. Use of antithrombolitic agents during pregnancy. Chest. 1992;102 (suppl 4):385S-390S.
PUBMED
54. Hull RD, Raskob GE, Pineo GF, et al. Subcutaneous low molecular weight heparin compared with continuous intravenous heparin in the treatment of proximal deep vein thrombosis. N Engl J Med. 1992;326:975-982.
ABSTRACT
55. Prandoni P, Lensing AWA, Buller HR, et al. Comparison of subcutaneous low molecular weight heparin with intravenous standard heparin in proximal deep vein thrombosis. Lancet. 1992;339:441-445.
PUBMED
56. Lensing AWA, Prins M, Koopman MMW, Buller H. Which heparin for proximal deep vein thrombosis? Lancet. 1992;340:311-312.
PUBMED
57. Bussey HI, Force RW, Bianco TM, Leonard AD. Reliance on prothrombin time ratios causes significant errors in anticoagulation therapy. Arch Intern Med. 1992;152:278-282.
FREE FULL TEXT
58. Hirsh J. Oral anticoagulant drugs. N Engl J Med. 1991;324:1865-1875.
PUBMED
59. Research Committee of the British Thoracic Society. Optimum duration of anticoagulation for deep vein thrombosis and pulmonary embolism. Lancet. 1992;340:873-876.
PUBMED
60. Heijboer H, Brandjes DPM, Buller HR, Sturk A, Wouter Ten Cate J. Deficiencies of coagulation inhibiting and fibrinolytic proteins in outpatients with deep vein thrombosis. N Engl J Med. 1990;323:1512-1516.
ABSTRACT
61. Silverstein RL, Nachman RL. Cancer and clotting—Trousseau's warning. N Engl J Med. 1992;327:1163-1164.
PUBMED
62. Prandoni P, Lensing AWA, Buller HR, et al. Deep vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med. 1992;327:1128-1133.
ABSTRACT
63. Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of out-patient therapy. Am J Med. 1989;87:144-152.
PUBMED
64. Comp PC, Elrod JP, Karzenski S. Warfarin induced skin necrosis. Semin Thromb Hemost. 1990;16:293-298.
PUBMED
65. Iturbe-Alessio I, Del Carmen Fonseca M, Mutchinik O, Santos MA, Zajarias A, Salazar E. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med. 1986;315:1390-1393.
ABSTRACT
66. Thrombolytic therapy in thrombosis: a National Institutes of Health Consensus Development Conference. Ann Intern Med. 1980;93:141-144.
PUBMED
67. Come PC, Kim D, Parker JA, Goldhaber SZ, Braunwald E, Markis JE. Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator. J Am Coll Cardiol. 1987;10:971-978.
ABSTRACT
68. Goldhaber SZ. Thrombolysis for pulmonary embolism. Prog Cardiovasc Dis. 1991;34:113-134.
PUBMED
69. Urokinase Pulmonary Embolism Trial Group. The Urokinase Pulmonary Embolism Trial. Circulation. 1973(suppl ll);47:1-108.
FREE FULL TEXT
70. Urokinase Pulmonary Embolism Trial Group. Urokinase-Streptokinase Embolism Trial: phase 2 results. JAMA. 1974;229:1606-1613.
FREE FULL TEXT
71. Sharma GVRK, Folland ED, Mclntyre KM, Sasahara AA. Long-term hemodynamic benefit of thrombolytic therapy in pulmonary embolic disease. J Am Coll Cardiol. 1990;15:65A. Abstract.
72. Sharma GVRK, Burleson VA, Sasahara AA. Effect of thrombolytic therapy on pulmonary capillary blood volume in patients with pulmonary embolism. N Engl J Med. 1980;303:842-845.
ABSTRACT
73. Tow DE, Wagner HN Jr. Recovery of pulmonary arterial blood flow in patients with pulmonary embolism. N Engl J Med. 1967;276:1053-1059.
PUBMED
74. Goldhaber SZ, Haire WD, Feldstein ML, et al. Altephase versus heparin in acute pulmonary embolism: randomized trial assessing right ventricular function and pulmonary perfusion. Lancet. 1993;341:507-511.
PUBMED
75. Arnesen H, Hoiseth A, Ly B. Streptokinase or heparin in the treatment of deep vein thrombosis: follow-up results of a prospective study. Acta Med Scand. 1982;211:65-68.
PUBMED
76. Théry C, Bauchart JJ, Lesenne M, et al. Predictive factors of effectiveness of streptokinase in deep vein thrombosis. Am J Cardiol. 1992;69:117-122.
PUBMED
77. Théry C, Asseman P, Amrounin I, et al. Use of a new removable vena cava filter in order to prevent pulmonary embolism in patients submitted to thrombolysis. Eur Heart J. 1990;11:334-341.
FREE FULL TEXT
78. Marder VJ, Sherry S. Thrombolytic therapy: current status, I. N Engl J Med. 1988;318:1512-1520.
PUBMED
79. ACC/AHA Task Force Report. Guidelines for the early management of patients with acute myocardial infarction. J Am Coll Cardiol. 1990;16:249-292.
PUBMED
80. Terrin M, Goldhaber SZ, Thompson B, the TIPE Investigators. Selection of patients with acute pulmonary embolism for thrombolytic therapy: Thrombolysis in Pulmonary Embolism (TIPE) Patient Survey. Chest. 1989(suppl);95:279S-281S.
PUBMED
81. Markel A, Manzo RA, Strandness DE Jr. The potential role of thrombolytic therapy in venous thrombosis. Arch Intern Med. 1992;152:1265-1267.
FREE FULL TEXT
82. Marder VJ, Sherry S. Thrombolytic therapy: current status, II. N Engl J Med. 1988:318:1585-1595.
PUBMED
83. Becker DM, Philbrick JT, Selby JB. Inferior vena cava filters: indications, safety, effectiveness. Arch Intern Med. 1992;152:1985-1994.
FREE FULL TEXT
84. Kanter B, Moser KM. The Greenfield vena cava filter. Chest. 1988;93:170-175.
PUBMED
85. Greenfield LJ, Cho KJ, Proctor MC, Sobel M, Shah S, Wingo J. Late results of suprarenal Greenfield vena cava filter placement. Arch Surg. 1992;127:969-973.
FREE FULL TEXT
86. Sasahard AA, Barsamian EM. Another look at pulmonary embolectomy. Ann Thorac Surg. 1973;16:317-319.
PUBMED
87. Mattox KL, Feldtman RW, Beall AC Jr, DeBakey ME. Pulmonary embolectomy for acute massive pulmonary embolism. Ann Surg. 1982;195:726-731.
PUBMED
88. Meyer G, Tamisier D, Sors H, et al. Pulmonary embolectomy: a 20-year experience at one center. Ann Thorac Surg. 1991;51:232-236.
ABSTRACT
89. Kieny R, Charpentier A, Kieny MT. What is the place of pulmonary embolectomy today? J Cardiovasc Surg. 1991;32:549-553.
PUBMED
90. Greenfield LJ, Kimmell GO, McCurdy WC. Transvenous removal of pulmonary emboli by vacuumcup catheter technique. J Surg Res. 1969;9:347-352.
PUBMED
91. Timsit JF, Reynaud P, Meyer G, Sors H. Pulmonary embolectomy by catheter device in massive pulmonary embolism. Chest. 1991;100:655-658.
PUBMED
92. Moser KM, Daily PO, Peterson K, et al. Throm-boendarterectomy for chronic major vessel thromboembolic pulmonary hypertenson. Ann Intern Med. 1987;107:560-565.
FREE FULL TEXT
93. Daily PO, Dembitsky WP, Iversen S, Moser KM, Auger W. Risk factors for pulmonary thromboendarterectomy. J Thorac Cardiovasc Surg. 1990;99:670-678.
ABSTRACT
94. Consensus Conference. Prevention of venous thrombosis and pulmonary embolism. JAMA. 1986;256:744-749.
FREE FULL TEXT
95. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A, Patwardhan NA. Physician practices in the prevention of venous thromboembolism. Ann Intern Med. 1991;115:591-595.
PUBMED
96. Knight MT, Dawson R. Effect of intermittent compression of the arms on deep venous thrombosis of the legs. Lancet. 1976;2:1265-1268.
PUBMED
97. Francis CW, Pellegrini VD Jr, Marder VJ, et al. Comparison of warfarin and external pneumatic compression in prevention of venous thrombosis after total hip replacement. JAMA. 1992;267:2911-2915.
FREE FULL TEXT
98. Colditz GA, Truden RL, Oster G. Rates of venous thrombosis after general surgery: combined results of randomized clinical trials. Lancet. 1986;2:143-146.
PUBMED
99. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedic, and urological surgery. N Engl J Med. 1988;318:1162-1173.
PUBMED
100. Gerhart TN, Yelt HS, Robertson LK, Lee MA, Smith M, Salzman EW. Low molecular weight heparinoid compared with warfarin for prophylaxis of deep vein thrombosis in patients who are operated on for fracture of the hip. J Bone Joint Surg Am. 1991;73A:494-502.
FREE FULL TEXT
|
